title: Screening for cancer in the patient with rheumatic disease.
abstract: This article begins with a discussion of the types of cancer that are most often the target of cancer screening in general medical practice. Colorectal, prostate, cervical, and breast cancer screening guidelines are reviewed and some of the evidence (and controversy) behind these recommendations is discussed. A discussion of some of the special risks for cancer in patients with rheumatologic disease follows, and some modifications of standard screening guidelines are suggested for these high-risk patients.
authors.affiliation: Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA.
authors.forename: K E
authors.initials: KE
authors.lastname: Bowles
authors.forename: C
authors.initials: C
authors.lastname: Wynne
authors.forename: M J
authors.initials: MJ
authors.lastname: Baime
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis; D015179:Colorectal Neoplasms / Q000175:diagnosis; D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000592:standards*; D009369:Neoplasms / Q000175:diagnosis*; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms / Q000175:diagnosis; D012216:Rheumatic Diseases / Q000150:complications*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis